ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Felzartamab Biosimilar - Anti-CD38 Antibody - BSA and Azide free (A338529)

$456

Humanized monoclonal antibody to CD38. Research grade Felzartamab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Felzartamab Biosimilar - Anti-CD38 Antibody - BSA and Azide free
Description
Humanized monoclonal antibody to CD38. Research grade Felzartamab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
2'-phospho-ADP-ribosyl cyclase, 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase, 2'-phospho-cyclic-ADP-ribose transferase, ADP-ribosyl cyclase 1, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, ADPRC 1, cADPR hydrolase 1, Cyclic ADP-ribose hydrolase 1, EC:2.4.99.20, T10
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Felzartamab Biosimilar - Anti-CD38 Antibody - BSA and Azide free (A338529)? Please let us know so that we can list the citation on this page.

Alternative products to Felzartamab Biosimilar - Anti-CD38 Antibody - BSA and Azide free (A338529)

Proteins predicted to interact with CD38

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.2% Relevancy Score
96.4% Relevancy Score
95.5% Relevancy Score
95% Relevancy Score
94.6% Relevancy Score
94.3% Relevancy Score
94% Relevancy Score
93.9% Relevancy Score
93.2% Relevancy Score